Absci Corp at Cowen Health Care Conference Transcript
So good afternoon. Steven Mah here on the Tools and Diagnostics team here at TD Cowen. Our next panel today is focused on synthetic biology-enabled drug discovery and AI-driven drug discovery. So similar to other transformational technologies such as the Internet, we believe synthetic biology and AI may become one of the most important technologies of our time, with the promise to address many of the global issues channel challenging us today, sustainability, high cost, affordability.
So with technology advancements such as gene editing, new R&D tools capable of generating huge amounts of biologically relevant data in single cells or in tissues, continuing lowering of R&D input costs, the lowering of computing costs, and increase in computing power, and the emergence of machine learning and generative AI. So we believe we're at the precipice of a new revolution in innovation and drug discovery which can deliver better and safer drugs at a faster and a much lower cost.
So today, our panelists are Sean McClain, Absci CEO and Founder; Stephen Dilly,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
